Integer (NYSE:ITGR) Stock Price Down 2.2% - Time to Sell?

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) dropped 2.2% during mid-day trading on Friday . The company traded as low as $115.28 and last traded at $115.82. Approximately 456,285 shares traded hands during mid-day trading, an increase of 45% from the average daily volume of 315,621 shares. The stock had previously closed at $118.40.

Analysts Set New Price Targets

ITGR has been the topic of a number of recent research reports. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research note on Wednesday, December 11th. KeyCorp upped their target price on Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Truist Financial upped their target price on Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Finally, Benchmark boosted their price target on Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Integer currently has an average rating of "Moderate Buy" and a consensus price target of $149.00.

Integer Trading Down 0.2 %

The firm has a market capitalization of $4.00 billion, a price-to-earnings ratio of 35.44, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The business has a fifty day moving average price of $133.82 and a 200 day moving average price of $132.69.

Remove Ads

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. As a group, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Institutional Trading of Integer

Several large investors have recently added to or reduced their stakes in ITGR. Raymond James Financial Inc. acquired a new stake in Integer in the 4th quarter valued at $38,073,000. Capital Research Global Investors increased its holdings in Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock valued at $186,960,000 after purchasing an additional 194,895 shares in the last quarter. Artisan Partners Limited Partnership acquired a new stake in Integer in the 4th quarter valued at $22,775,000. Eagle Asset Management Inc. acquired a new stake in Integer in the 3rd quarter valued at $14,403,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Integer in the 4th quarter valued at $7,889,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.